BIO 2022 Notebook: Future Directions For R&D
Executive Summary
News and views from day four of the BIO annual meeting include a fireside chat with FDA commissioner Robert Califf, gene therapy insights, and pharma efforts to provide cancer medicines in lower income countries.
You may also be interested in...
The Old Order Changeth: Women CEOs at Foreign Firms In India Chart New Course
Foreign firms including Merck KGaA, Boehringer Ingelheim, Takeda and Sanofi’s vaccines business are being led by women in India, a fiercely competitive, largely out-of-pocket market. There’s a lot riding on these female leaders as they seek to drive business growth and potentially change the paradigm around the gender gap in pharma at the top.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast version of Five Must-Know Things: Genmab confident in CD20xCD3 battle; Alzheimer’s disappointment for Roche; Japan speed bump for Shionogi’s oral COVID antiviral; pharma’s view of psychedelics; and a roundup of key BIO sessions.
Global Cancer Coalition Seeks To Boost Access To Medicines In Lower-Income Countries
The Union for International Cancer Control and its industry and other partners say the Access to Oncology Medicines Coalition will help to facilitate access to cancer drugs in low- and lower-middle-income countries.